In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
Authors
Keywords
-
Journal
Nature Nanotechnology
Volume 11, Issue 3, Pages 295-303
Publisher
Springer Nature
Online
2015-12-22
DOI
10.1038/nnano.2015.292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
- (2015) R. Winograd et al. Cancer Immunology Research
- A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types
- (2015) Bettina Huber et al. PLoS One
- Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple Adjuvants
- (2014) Omar A. Ali et al. CANCER RESEARCH
- Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung
- (2014) Agnieszka Rynda-Apple et al. Nanomedicine
- Stimulating antitumor immunity with nanoparticles
- (2014) Mee Rie Sheen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Biomimetic Antigenic Nanoparticles Elicit Controlled Protective Immune Response to Influenza
- (2013) Dustin P. Patterson et al. ACS Nano
- Aire Deficiency Promotes TRP-1-Specific Immune Rejection of Melanoma
- (2013) M.-L. Zhu et al. CANCER RESEARCH
- Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment
- (2013) Jason R. Baird et al. CANCER RESEARCH
- CD11c+cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice
- (2013) Laura E. Richert et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: Cargo-loading and delivery
- (2013) Ibrahim Yildiz et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle Adjuvant Sensing by TLR7 Enhances CD8+ T Cell-Mediated Protection from Listeria Monocytogenes Infection
- (2013) M.-E. Lebel et al. JOURNAL OF IMMUNOLOGY
- Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen-Specific CD8 T Cells
- (2013) E. Clancy-Thompson et al. Cancer Immunology Research
- Virus-Like Particle-Induced Protection Against MRSA Pneumonia Is Dependent on IL-13 and Enhancement of Phagocyte Function
- (2012) Agnieszka Rynda-Apple et al. AMERICAN JOURNAL OF PATHOLOGY
- Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge
- (2012) J. R. Baird et al. JOURNAL OF IMMUNOLOGY
- Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen
- (2012) A. Link et al. JOURNAL OF IMMUNOLOGY
- CPMV-DOX Delivers
- (2012) Alaa A. A. Aljabali et al. MOLECULAR PHARMACEUTICS
- Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age
- (2012) Scott A. Halperin et al. VACCINE
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation
- (2011) D. S. Abi Abdallah et al. INTERNATIONAL IMMUNOLOGY
- Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells
- (2011) Nicole F Steinmetz et al. Nanomedicine
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophil activation and survival are modulated by interaction with NK cells
- (2010) C. Costantini et al. INTERNATIONAL IMMUNOLOGY
- Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model
- (2010) Jadwiga Jablonska et al. JOURNAL OF CLINICAL INVESTIGATION
- Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
- (2010) Dong-Ming Kuang et al. JOURNAL OF HEPATOLOGY
- Evidence for a cross-talk between human neutrophils and Th17 cells
- (2009) M. Pelletier et al. BLOOD
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells
- (2009) U. K. Scarlett et al. CANCER RESEARCH
- Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory Viruses
- (2009) James A. Wiley et al. PLoS One
- Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo
- (2009) Maria J. Gonzalez et al. PLoS One
- Efficient generation of cowpea mosaicvirus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants
- (2009) Keith Saunders et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More